Cargando…

Comparative metabolomic analysis of HPAC cells following the acquisition of erlotinib resistance

Pancreatic cancer is one of the most lethal types of cancer, due to difficulty in early detection and the limited efficacy of available treatments. Erlotinib is used to inhibit the epidermal growth factor receptor for the treatment of pancreatic cancer; however, erlotinib resistance is a major issue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sooyeun, Jang, Won-Jun, Choi, Boyeon, Joo, Sang Hoon, Jeong, Chul-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431587/ https://www.ncbi.nlm.nih.gov/pubmed/28529573 http://dx.doi.org/10.3892/ol.2017.5940

Ejemplares similares

Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells
por: Jang, Won-Jun, et al.
Publicado: (2017)

Current Understanding of Methamphetamine-Associated Metabolic Changes Revealed by the Metabolomics Approach
por: Kim, Minjeong, et al.
Publicado: (2019)

Revealing Metabolic Perturbation Following Heavy Methamphetamine Abuse by Human Hair Metabolomics and Network Analysis
por: Kim, Suji, et al.
Publicado: (2020)

HpaC Controls Substrate Specificity of the Xanthomonas Type III Secretion System
por: Lorenz, Christian, et al.
Publicado: (2008)

Hair Metabolomics in Animal Studies and Clinical Settings
por: Jang, Won-Jun, et al.
Publicado: (2019)

Effect of Matrine on HPAC cell migration by down-regulating the expression of MT1-MMP via Wnt signaling
por: Ma, Yongchao, et al.
Publicado: (2015)

Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case report
por: Ohara, Sayaka, et al.
Publicado: (2014)

Transcriptional Profiling of Whisker Follicles and of the Striatum in Methamphetamine Self-Administered Rats
por: Jang, Won-Jun, et al.
Publicado: (2020)

Identification of Potential Biomarkers for Diagnosis of Patients with Methamphetamine Use Disorder
por: Jang, Won-Jun, et al.
Publicado: (2023)

Secretion of early and late substrates of the type III secretion system from Xanthomonas is controlled by HpaC and the C-terminal domain of HrcU
por: Lorenz, Christian, et al.
Publicado: (2011)

Erlotinib Induced Trichomegaly of the Eyelashes
por: Jeon, Sang-Hoon, et al.
Publicado: (2013)

Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study
por: Kim, Min Kyoung, et al.
Publicado: (2018)

Striatal miR-183-5p inhibits methamphetamine-induced locomotion by regulating glucocorticoid receptor signaling
por: Song, Sang-Hoon, et al.
Publicado: (2022)

Transcriptome profiling of whisker follicles in methamphetamine self-administered rats
por: Song, Sang-Hoon, et al.
Publicado: (2018)

2-Deoxy-d-Glucose-Induced Metabolic Alteration in Human Oral Squamous SCC15 Cells: Involvement of N-Glycosylation of Axl and Met
por: Lee, Naeun, et al.
Publicado: (2019)

Combination Erlotinib-Cisplatin and Atg3-Mediated Autophagy in Erlotinib Resistant Lung Cancer
por: Lee, Jasmine G., et al.
Publicado: (2012)

N-Cadherin Expression Is Associated with Acquisition of EMT Phenotype and with Enhanced Invasion in Erlotinib-Resistant Lung Cancer Cell Lines
por: Zhang, Xiaoju, et al.
Publicado: (2013)

A Case of Cicatricial Alopecia Associated with Erlotinib
por: Yang, Bo Hee, et al.
Publicado: (2011)

Alterations in Pharmacokinetics of Gemcitabine and Erlotinib by Concurrent Administration of Hyangsayukgunja-Tang, a Gastroprotective Herbal Medicine
por: Kim, Tae Hwan, et al.
Publicado: (2017)

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway
por: Park, Ji-Hyun, et al.
Publicado: (2017)

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
por: Lim, Jae Yun, et al.
Publicado: (2015)

Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment
por: Orzáez, M, et al.
Publicado: (2012)

Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts
por: IWAI, TOSHIKI, et al.
Publicado: (2011)

Comparison of Homologous Recombination Repair Gene Next-Generation Sequencing Analysis in Patients With Metastatic Castration-Resistant Prostate Cancer Between Local and Central Laboratories in Korea
por: Kim, Yoonjung, et al.
Publicado: (2023)

Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin Rash
por: Lee, Won Kil, et al.
Publicado: (2023)

Clinical Factors Associated with Acquisition of Resistance to Levofloxacin in Stenotrophomonas maltophilia
por: Baek, Ji Hyeon, et al.
Publicado: (2014)

Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2014)

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
por: Pao, William, et al.
Publicado: (2005)

Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives
por: Tang, Joy, et al.
Publicado: (2013)

Nutritional evaluation of new alternative types of dog foods including raw and cooked homemade-style diets
por: Choi, Boyeon, et al.
Publicado: (2023)

Successful erlotinib rechallenge after both gefitinib- and erlotinib-induced interstitial lung diseases
por: Arakawa, Nobuhito, et al.
Publicado: (2013)

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016)

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
por: Kim, Youjin, et al.
Publicado: (2019)

Efficacy of newly discovered DNA aptamers targeting AXL in a lung cancer cell with acquired resistance to Erlotinib
por: Hwang, Ji An, et al.
Publicado: (2021)

Epicatechin Prevents Methamphetamine-Induced Neuronal Cell Death via Inhibition of ER Stress
por: Kang, Youra, et al.
Publicado: (2019)

Erlotinib-induced dry eye
por: Ravisankar, Rashmita, et al.
Publicado: (2023)

Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer
por: Ciuleanu, Tudor-Eliade, et al.
Publicado: (2017)

IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
por: Fernando, Romaine I., et al.
Publicado: (2016)

Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells
por: Huang, Keqiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n2jreocvuhu68m238tpvleeq67